{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T06:17:51Z","timestamp":1794205071187,"version":"4.8.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>We aimed to evaluate the effectivity and safety of botulinum toxin A (BT-A) to reduce sialorrhea in children with hypersalivation due to neurological diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients who had a complaint of severe sialorrhea were included in the study. Drooling severity of the patients was evaluated using the classification of Thomas-Stonell and Greenberg. The frequency of aspiration before and after the procedure was recorded. The 24-hour saliva amount and mean duration of two consecutive aspirations were recorded. BT-A was injected into the bilateral parotid and submandibular glands by a otorhinolaryngologist under the guidance of ultrasound guidance (USG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      When patients' mean drooling severity scores, drooling frequency scores, mean duration of two consecutive aspirations, and amount of saliva collected before and after procedure were compared, a statistical significance was observed. One-year hospital records before after and injection were examined and it was observed that after BT-A injection, hospital visits were statistically significantly low (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>BT-A injection into salivary glands is well tolerated, is minimally invasive, has low complication rates and should be performed into both parotid and submandibular glands under USG. Although there is still no consensus on the ideal dose and frequency of injections, it is thought that a dose of 1U\/kg\/gland can be used with safety in pediatric age groups and the dimensions of the salivary glands and quantitative measurements of the amount of saliva should be utilized. Larger studies involving more patients are required in order to constitute a standard injection protocol.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_85_20","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T01:48:22Z","timestamp":1623462502000},"page":"847-852","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of Sialorrhea with Botulinum Toxin A Injection in Children"],"prefix":"10.4103","volume":"24","author":[{"given":"E","family":"T\u00fcre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Yazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"D\u00fcndar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bakdik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pekcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20240907","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archoto.2009.110","article-title":"Surgical management of drooling: A meta-analysis","volume":"135","author":"Reed","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R2-10-20240907","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/000992289203100203","article-title":"Drooling. Experience with team assessment and management","volume":"31","author":"Crysdale","year":"1992","journal-title":"Clin Pediatr"},{"key":"R3-10-20240907","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","article-title":"Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study","volume":"154","author":"Mier","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R4-10-20240907","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archoto.2010.240","article-title":"Botulinum toxin A for treatment of sialorrhea in children: An effective, minimally invasive approach","volume":"137","author":"Khan","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R5-10-20240907","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clindermatol.2003.12.029","article-title":"Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis","volume":"22","author":"Kreyden","year":"2004","journal-title":"Clin Dermatol"},{"key":"R6-10-20240907","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","article-title":"Three treatment approaches and clinical factors in the reduction of drooling","volume":"3","author":"Thomas-Stonell","year":"1988","journal-title":"Dysphagia"},{"key":"R7-10-20240907","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/pch\/4.6.406","article-title":"Drooling in children","volume":"4","author":"Alexander","year":"1999","journal-title":"Paediatr Child Health"},{"key":"R8-10-20240907","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1469-8749.2001.tb00225.x","article-title":"Management of drooling in individuals with neurodisability: A surgical experience","volume":"43","author":"Crysdale","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"R10-10-20240907","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s004310100784","article-title":"Botulinum toxin A: A new option for treatment of drooling in children with cerebral palsy. Presentation of a case series","volume":"160","author":"Jongerius","year":"2001","journal-title":"Eur J Pediatr"},{"key":"R11-10-20240907","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005537-200201000-00014","article-title":"Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy","volume":"112","author":"Suskind","year":"2002","journal-title":"Laryngoscope"},{"key":"R12-10-20240907","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jradnu.2009.12.002","article-title":"Ultrasound-guided Botox injections of salivary glands in children with drooling","volume":"29","author":"Meece","year":"2010","journal-title":"J Radiol Nurs"},{"key":"R13-10-20240907","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-2003-43237","article-title":"Experimental and clinical investigations on the inhibition of secretion of the major salivary glands with botulinum toxin A","volume":"82","author":"Ellies","year":"2003","journal-title":"Laryngorhinootologie"},{"key":"R14-10-20240907","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bjoms.2012.07.012","article-title":"Ultrasound-guided injection of botulinum toxin A into the submandibular gland in children and young adults with sialorrhoea","volume":"51","author":"Gok","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R15-10-20240907","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijporl.2016.06.031","article-title":"Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience","volume":"88","author":"Mahadevan","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R16-10-20240907","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0012-1622.2008.02010.x","article-title":"Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders","volume":"50","author":"Reid","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"R17-10-20240907","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0887-8994(02)00381-8","article-title":"Botulinum toxin A as a treatment for excessive drooling in children","volume":"27","author":"Bothwell","year":"2002","journal-title":"Pediatr Neurol"},{"key":"R18-10-20240907","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pediatrneurol.2015.09.014","article-title":"Ultrasound-guided botulinum toxin type a salivary gland injection in children for refractory sialorrhea: 10-year experience at a large tertiary children's hospital","volume":"54","author":"Lungren","year":"2016","journal-title":"Pediatr Neurol"},{"key":"R19-10-20240907","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jamaoto.2013.1328","article-title":"Long-term safety and efficacy data on botulinum toxin type A: An injection for sialorrhea","volume":"139","author":"Chan","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R20-10-20240907","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/01.WNL.0000142040.57474.A6","article-title":"Botulinum toxin effect on salivary flow rate in children with cerebral palsy","volume":"63","author":"Jongerius","year":"2004","journal-title":"Neurology"},{"key":"R21-10-20240907","doi-asserted-by":"crossref","first-page":"E328","DOI":"10.1002\/lary.25222","article-title":"Effect of recurrent onabotulinum toxin A injection into the salivary glands: An ultrasound measurement","volume":"125","author":"Cardona","year":"2015","journal-title":"Laryngoscope"},{"key":"R22-10-20240907","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling: A controlled clinical trial","volume":"114","author":"Jongerius","year":"2004","journal-title":"Pediatrics"},{"key":"R23-10-20240907","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00405-007-0254-8","article-title":"Histopathological and radiological investigations of the influence of botulinum toxin on the submandibular gland of the rat","volume":"264","author":"Coskun","year":"2007","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R24-10-20240907","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.70.4.538","article-title":"Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders","volume":"70","author":"Porta","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R25-10-20240907","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0883073811419365","article-title":"Drooling: Are botulinum toxin injections into the maj\u00f6r salivary glands a good treatment option?","volume":"27","author":"Nordgarden","year":"2012","journal-title":"J Child Neurol"},{"key":"R26-10-20240907","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ijporl.2015.05.010","article-title":"Drooling quantification: Correlation of different techniques","volume":"79","author":"Rashnoo","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R27-10-20240907","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijporl.2005.07.021","article-title":"Saliva control issues in the neurologically challenged. A 30 year experience in team management","volume":"70","author":"Crysdale","year":"2006","journal-title":"Int J Pediatr Otorhinolaryngol"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_85_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:16:41Z","timestamp":1787843801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_85_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_85_20","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}